Susanne Dorn - Pharnext Chief Officer
| ALPHA Stock | EUR 0.0002 0.00 0.00% |
Insider
Susanne Dorn is Chief Officer of Pharnext SA
| Phone | 33 1 41 09 22 30 |
| Web | https://www.pharnext.com |
Pharnext Management Efficiency
The company has return on total asset (ROA) of (0.7578) % which means that it has lost $0.7578 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (13.4844) %, meaning that it generated substantial loss on money invested by shareholders. Pharnext's management efficiency ratios could be used to measure how well Pharnext manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| JeanPascal PharmD | OSE Pharma SA | N/A | |
| Raquel Lizarraga | Abivax SA | N/A | |
| Scott Jeffers | Gensight Biologics SA | N/A | |
| Pr Roska | Gensight Biologics SA | N/A | |
| Prof Cepko | Gensight Biologics SA | N/A | |
| Paul Gineste | Abivax SA | N/A | |
| Philippe MD | Abivax SA | 65 | |
| Silvia MD | OSE Pharma SA | N/A | |
| Dominique MD | OSE Pharma SA | 68 | |
| JoseAlain MD | Gensight Biologics SA | N/A | |
| Clothilde Caillet | Gensight Biologics SA | N/A | |
| Brangre Vasseur | OSE Pharma SA | N/A | |
| FFPM MBA | Biophytis SA | 52 | |
| Pierre MBA | Abivax SA | N/A | |
| Linda MSc | OSE Pharma SA | 56 | |
| Alain MD | OSE Pharma SA | N/A | |
| Regina Jehle | Abivax SA | N/A | |
| Teylan | Biophytis SA | N/A | |
| Philippe Rousseau | Biophytis SA | 52 | |
| Serge Picaud | Gensight Biologics SA | N/A | |
| Benoit Canolle | Biophytis SA | 45 | |
Management Performance
| Return On Equity | -13.48 | |||
| Return On Asset | -0.76 |
Pharnext SA Leadership Team
Elected by the shareholders, the Pharnext's board of directors comprises two types of representatives: Pharnext inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharnext. The board's role is to monitor Pharnext's management team and ensure that shareholders' interests are well served. Pharnext's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharnext's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joshua Schafer, Interim Chairman | ||
| Xavier MSc, Chief Officer | ||
| Rodolphe Hajj, Chief Officer | ||
| Susanne Dorn, Chief Officer | ||
| Daniel Cohen, Director | ||
| DSc Chumakov, Chairman CoFounder | ||
| Rob Quinn, Chief Officer | ||
| Philippe Rinaudo, Chief Officer | ||
| David MD, CEO Director | ||
| Antoine Gravelle, G Counsel | ||
| Viviane Bertrand, Chief Officer |
Pharnext Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pharnext a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.48 | |||
| Return On Asset | -0.76 | |||
| Operating Margin | (9.13) % | |||
| Current Valuation | 20.06 M | |||
| Shares Outstanding | 875.25 M | |||
| Shares Owned By Insiders | 0.68 % | |||
| Shares Owned By Institutions | 0.04 % | |||
| Price To Book | 24.54 X | |||
| Price To Sales | 0.1 X | |||
| Revenue | 84.78 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pharnext Stock Analysis
When running Pharnext's price analysis, check to measure Pharnext's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharnext is operating at the current time. Most of Pharnext's value examination focuses on studying past and present price action to predict the probability of Pharnext's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharnext's price. Additionally, you may evaluate how the addition of Pharnext to your portfolios can decrease your overall portfolio volatility.